Biotech, cancer, VC

MolecularMD Raises $3M

Luke Timmerman 2/2/09

MolecularMD, a Portland, OR-based maker of molecular diagnostic tests for cancer, has raised $3 million in a new round of financing, according to data from VentureDeal. The company was founded in 2006 on technology from Brian Druker and Michael Heinrich at Oregon Health & Science University.

Luke Timmerman is the National Biotechnology Editor for Xconomy. You can e-mail him at ltimmerman@xconomy.com, call 206-624-2374, or follow him on Twitter at http://twitter.com/ldtimmerman.